Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarit Cohen Rabbie

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
International Journal of Pharmaceutics|March 12, 2015
Inter-subject variability in intestinal drug solubilitySarit Cohen Rabbie, Talia Flanagan, Paul D Martin, et al.
Clinical Therapeutics|April 12, 2022
A Phase I, Open-label, Randomized, Crossover Study of the Relative Bioavailability of Capsule and Granule Formulations of SelumetinibSarit Cohen-Rabbie, Alexandra Mattinson, Karen So, et al.
Clinical and Translational Science|February 16, 2022
Effect of food on capsule and granule formulations of selumetinibSarit Cohen-Rabbie, Alexandra Mattinson, Karen So, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 14, 2016
Estimating the variability in fraction absorbed as a paradigm for informing formulation development in early clinical drug developmentSarit Cohen Rabbie, Paul D Martin, Talia Flanagan, et al.
Journal of Clinical Pharmacology|February 24, 2021
QT Prolongation Risk Assessment in Oncology: Lessons Learned From Small-Molecule New Drug Applications Approved During 2011-2019Sarit Cohen-Rabbie, Alienor C Berges, Dinko Rekić, et al.
Journal of Clinical Pharmacology|July 1, 2021
Physiologically Based Pharmacokinetic Modeling for Selumetinib to Evaluate Drug-Drug Interactions and Pediatric Dose RegimensSarit Cohen-Rabbie, Li Zhou, Karthick Vishwanathan, et al.
Cancer Chemotherapy and Pharmacology|April 27, 2021
Population pharmacokinetics and exposure-response of selumetinib and its N-desmethyl metabolite in pediatric patients with neurofibromatosis type 1 and inoperable plexiform neurofibromasStein Schalkwijk, Li Zhou, Sarit Cohen-Rabbie, et al.
British Journal of Clinical Pharmacology|August 20, 2021
Concentration-QT modelling in early clinical oncology settings: Simulation evaluation of performanceGael Cantet, Alienor Berges, Rhianna O'Sullivan, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
International Journal of Pharmaceutics|March 12, 2015
Inter-subject variability in intestinal drug solubilitySarit Cohen Rabbie, Talia Flanagan, Paul D Martin, et al.
Clinical Therapeutics|April 12, 2022
A Phase I, Open-label, Randomized, Crossover Study of the Relative Bioavailability of Capsule and Granule Formulations of SelumetinibSarit Cohen-Rabbie, Alexandra Mattinson, Karen So, et al.
Clinical and Translational Science|February 16, 2022
Effect of food on capsule and granule formulations of selumetinibSarit Cohen-Rabbie, Alexandra Mattinson, Karen So, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 14, 2016
Estimating the variability in fraction absorbed as a paradigm for informing formulation development in early clinical drug developmentSarit Cohen Rabbie, Paul D Martin, Talia Flanagan, et al.
Journal of Clinical Pharmacology|February 24, 2021
QT Prolongation Risk Assessment in Oncology: Lessons Learned From Small-Molecule New Drug Applications Approved During 2011-2019Sarit Cohen-Rabbie, Alienor C Berges, Dinko Rekić, et al.
Journal of Clinical Pharmacology|July 1, 2021
Physiologically Based Pharmacokinetic Modeling for Selumetinib to Evaluate Drug-Drug Interactions and Pediatric Dose RegimensSarit Cohen-Rabbie, Li Zhou, Karthick Vishwanathan, et al.
Cancer Chemotherapy and Pharmacology|April 27, 2021
Population pharmacokinetics and exposure-response of selumetinib and its N-desmethyl metabolite in pediatric patients with neurofibromatosis type 1 and inoperable plexiform neurofibromasStein Schalkwijk, Li Zhou, Sarit Cohen-Rabbie, et al.
British Journal of Clinical Pharmacology|August 20, 2021
Concentration-QT modelling in early clinical oncology settings: Simulation evaluation of performanceGael Cantet, Alienor Berges, Rhianna O'Sullivan, et al.
Pageof 1